Developments Eiger gets FDA breakthrough therapy designation for HDV drug candidate Eiger BioPharmaceuticals’ (NASDAQ:EIGR) peginterferon lambda (lambda) received FDA breakthrough therapy designation for the treatment of hepatitis delta virus (HDV) infection. HDV is the most severe form of human viral... August 21, 2019